Lily Colahan's corporate practice includes advising public and private companies in a broad array of business activities and transactions, with a focus on the technology and life sciences sectors.

Download full bio 

Experience

  • Oncorus – $98 Million IPO 

  • COMPASS Pathways – $147 Million IPO 

  • Vital Farms – $235.4 Million IPO 

  • Karuna Therapeutics $103 million IPO 

  • Akero Therapeutics - $106 Million IPO 

  • View all

Education

  • Fordham University School of Law
    JD, magna cum laude, 2014

  • Tufts University
    BA, 2011


Admissions & Credentials

Massachusetts

New York

Media & Insight